| Project/Area Number |
23K24566
|
|---|
| Project/Area Number (Other) |
22H03308 (2022-2023)
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Multi-year Fund (2024)
Single-year Grants (2022-2023) |
|---|
| Section | 一般 |
|---|
| Review Section |
Basic Section 58010:Medical management and medical sociology-related
|
|---|
| Research Institution | Hitotsubashi University |
|---|
Principal Investigator |
Rahman Mizanur 一橋大学, 社会科学高等研究院, 准教授 (10726433)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
中村 良太 一橋大学, 社会科学高等研究院, 教授 (00717209)
佐藤 主光 一橋大学, 社会科学高等研究院, 教授 (50313458)
ALAM MD・ASHRAFUL 東京大学, 医学部附属病院, 特任研究員 (80866632)
|
|---|
| Project Period (FY) |
2022-04-01 – 2025-03-31
|
| Project Status |
Granted (Fiscal Year 2024)
|
| Budget Amount *help |
¥17,030,000 (Direct Cost: ¥13,100,000、Indirect Cost: ¥3,930,000)
Fiscal Year 2024: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2023: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
Fiscal Year 2022: ¥8,970,000 (Direct Cost: ¥6,900,000、Indirect Cost: ¥2,070,000)
|
|---|
| Keywords | Hypertension control / Community pharmacy / Quality of life / Cost-effectiveness / Pharmacy / Health promotion / Treatment adherence / Blood pressure / Cluster RCT / hypertension |
|---|
| Outline of Research at the Start |
Our study evaluates the impact of pharmacy-based health promotion on hypertensive patients in resource-limited areas by using a cluster-randomized trial. There are 3,600 hypertensive adults in Bangladesh and 360 in Pakistan participating. Phases include baseline surveys with interventions, midline surveys with interventions and follow-ups, and endline surveys with impact evaluations. Two intervention groups will provide community pharmacies with educational training, counseling, phone calls, and text messages. Blood pressure, quality of life, and cost-effectiveness will also be measured.
|
